Guideline-concordant multimodal therapy associated with improved mortality outcomes in patients with high-risk prostate cancer
1. Among patients with high-risk prostate cancer receiving guideline-concordant multimodal therapy, prostate cancer-specific mortality outcomes were equivalent among radical prostatectomy, ...